Clinical profile of cerebral malaria at a secondary care hospital

Introduction: Cerebral malaria (CM) is one of the most common causes for non-traumatic encephalopathy in the world. It affects both the urban and rural population. It is a challenge to treat these patients in a resource limited setting; where majority of these cases present. Materials and Methods: T...

Full description

Bibliographic Details
Main Authors: Jency Maria Koshy, Jacob Koshy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2014;volume=3;issue=1;spage=54;epage=57;aulast=Koshy
id doaj-177b675f7f094e81834c665730c8e12f
record_format Article
spelling doaj-177b675f7f094e81834c665730c8e12f2020-11-25T00:35:57ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632014-01-0131545710.4103/2249-4863.130276Clinical profile of cerebral malaria at a secondary care hospitalJency Maria KoshyJacob KoshyIntroduction: Cerebral malaria (CM) is one of the most common causes for non-traumatic encephalopathy in the world. It affects both the urban and rural population. It is a challenge to treat these patients in a resource limited setting; where majority of these cases present. Materials and Methods: This was a prospective study carried out from September 2005 to December 2006 at Jiwan Jyoti Christian Hospital in Eastern Uttar Pradesh in India. This is a secondary level care with limited resources. We studied the clinical profile, treatment and outcome of all the patients above the age of 14 years diagnosed with CM. Results: There were a total of 53 patients with CM of which 38 (71.7%) of them were females. Among them, 35 (66%) patients were less than 30 years of age. The clinical features noted were seizure (39.62%), anemia (84.9%), icterus (16.98%), hypotension (13.2%), bleeding (3.7%), hepatomegaly (5.66%), splenomegaly (5.66%), non-cardiogenic pulmonary edema (16.98%) and renal dysfunction (37.36%). Co-infection with Plasmodium vivax was present in 13 (24.53%) of them. Treatment received included artesunin compounds or quinine. Median time of defervescence was 2 (interquartile range1-3). Complete recovery was achieved in 43 (81%) of them. Two (3.7%) of them died. Conclusion: CM, once considered to be a fatal disease has shown remarkable improvement in the outcome with the wide availability of artesunin and quinine components. To combat the malaria burden, physicians in resource limited setting should be well trained to manage these patients especially in the endemic areas. The key to management is early diagnosis and initiation of treatment based on a high index of suspicion. Anticipation and early recognition of the various complications are crucial.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2014;volume=3;issue=1;spage=54;epage=57;aulast=KoshyCerebral malariaclinical profilesecondary care hospital
collection DOAJ
language English
format Article
sources DOAJ
author Jency Maria Koshy
Jacob Koshy
spellingShingle Jency Maria Koshy
Jacob Koshy
Clinical profile of cerebral malaria at a secondary care hospital
Journal of Family Medicine and Primary Care
Cerebral malaria
clinical profile
secondary care hospital
author_facet Jency Maria Koshy
Jacob Koshy
author_sort Jency Maria Koshy
title Clinical profile of cerebral malaria at a secondary care hospital
title_short Clinical profile of cerebral malaria at a secondary care hospital
title_full Clinical profile of cerebral malaria at a secondary care hospital
title_fullStr Clinical profile of cerebral malaria at a secondary care hospital
title_full_unstemmed Clinical profile of cerebral malaria at a secondary care hospital
title_sort clinical profile of cerebral malaria at a secondary care hospital
publisher Wolters Kluwer Medknow Publications
series Journal of Family Medicine and Primary Care
issn 2249-4863
publishDate 2014-01-01
description Introduction: Cerebral malaria (CM) is one of the most common causes for non-traumatic encephalopathy in the world. It affects both the urban and rural population. It is a challenge to treat these patients in a resource limited setting; where majority of these cases present. Materials and Methods: This was a prospective study carried out from September 2005 to December 2006 at Jiwan Jyoti Christian Hospital in Eastern Uttar Pradesh in India. This is a secondary level care with limited resources. We studied the clinical profile, treatment and outcome of all the patients above the age of 14 years diagnosed with CM. Results: There were a total of 53 patients with CM of which 38 (71.7%) of them were females. Among them, 35 (66%) patients were less than 30 years of age. The clinical features noted were seizure (39.62%), anemia (84.9%), icterus (16.98%), hypotension (13.2%), bleeding (3.7%), hepatomegaly (5.66%), splenomegaly (5.66%), non-cardiogenic pulmonary edema (16.98%) and renal dysfunction (37.36%). Co-infection with Plasmodium vivax was present in 13 (24.53%) of them. Treatment received included artesunin compounds or quinine. Median time of defervescence was 2 (interquartile range1-3). Complete recovery was achieved in 43 (81%) of them. Two (3.7%) of them died. Conclusion: CM, once considered to be a fatal disease has shown remarkable improvement in the outcome with the wide availability of artesunin and quinine components. To combat the malaria burden, physicians in resource limited setting should be well trained to manage these patients especially in the endemic areas. The key to management is early diagnosis and initiation of treatment based on a high index of suspicion. Anticipation and early recognition of the various complications are crucial.
topic Cerebral malaria
clinical profile
secondary care hospital
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2014;volume=3;issue=1;spage=54;epage=57;aulast=Koshy
work_keys_str_mv AT jencymariakoshy clinicalprofileofcerebralmalariaatasecondarycarehospital
AT jacobkoshy clinicalprofileofcerebralmalariaatasecondarycarehospital
_version_ 1725306864455909376